Repository logo
 
Publication

Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases

dc.contributor.authorFigueiredo-Nunes, Inês
dc.contributor.authorTrigueiro-Louro, João
dc.contributor.authorRebelo-de-Andrade, Helena
dc.date.accessioned2023-03-21T12:21:49Z
dc.date.available2023-03-21T12:21:49Z
dc.date.issued2022-11-18
dc.description.abstractInfluenza and COVID-19 are infectious respiratory diseases that represent a major concern to public health with social and economic impact worldwide, for which the available therapeutic options are not satisfactory. The RdRp has a central role in viral replication and thus represents a major target for the development of antiviral approaches. In this study, we focused on Influenza A virus PB1 polymerase protein and the betacoronaviruses nsp12 polymerase protein, considering their functional and structural similarities. We have performed conservation and druggability analysis to map conserved druggable regions, that may have functional or structural importance in these proteins. We disclosed the most promising and new targeting regions for the discovery of new potential polymerase inhibitors. Conserved druggable regions of putative interaction with favipiravir and molnupiravir were also mapped. We have also compared and integrated the current findings with previous research.pt_PT
dc.description.abstractHighlights: IAV PB1 and beta-CoVs nsp12 RdRp proteins bear/have highly conserved regions; Fingers and palm subdomains of the RdRp proteins represent the most promising regions; Over 150 new top-ranked hot spots were identified for each protein; New conserved druggable pockets suitable for drug modulation were disclosed.pt_PT
dc.description.sponsorshipThis work was supported by the grant PD/BD/128402/2017 from Fundação para a Ciência e a Tecnologia (FCT) PhD Programme in Medicines and Pharmaceutical Innovation (i3DU)pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationVirology. 2023 Jan;578:45-60. doi: 10.1016/j.virol.2022.11.001. Epub 2022 Nov 18.pt_PT
dc.identifier.doi10.1016/j.virol.2022.11.001pt_PT
dc.identifier.issn0042-6822
dc.identifier.urihttp://hdl.handle.net/10400.18/8587
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relationNS1 como alvo terapêutico emergente: na procura de novos fármacos contra o vírus influenza
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S004268222200191X?via%3Dihubpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectSARS-CoV-2pt_PT
dc.subjectCOVID-19pt_PT
dc.subjectBetacoronavirusespt_PT
dc.subjectConsensus Druggable Pocketpt_PT
dc.subjectConservation Scorept_PT
dc.subjectDruggability Scorept_PT
dc.subjectInfluenza A Viruspt_PT
dc.subjectPB1 Proteinpt_PT
dc.subjectInfluenzapt_PT
dc.subjectnsp12 Proteinpt_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.subjectResistência aos Antimicrobianospt_PT
dc.titleExploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerasespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleNS1 como alvo terapêutico emergente: na procura de novos fármacos contra o vírus influenza
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//PD%2FBD%2F128402%2F2017/PT
oaire.citation.endPage60pt_PT
oaire.citation.startPage45pt_PT
oaire.citation.titleVirologypt_PT
oaire.citation.volume578pt_PT
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.embargofctAcesso de acordo com política editorial da revista.pt_PT
rcaap.rightsembargoedAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublication7ea88733-a953-4463-97e1-5a85fe025637
relation.isProjectOfPublication.latestForDiscovery7ea88733-a953-4463-97e1-5a85fe025637

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1-s2.0-S004268222200191X-main.pdf
Size:
8.7 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: